###begin article-title 0
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells
###end article-title 0
###begin p 1
A. Holz's present address is Department of Cellular and Molecular Biology, Technical University of Braunschweig, D-38106 Braunschweig, Germany.
###end p 1
###begin p 2
B. Pllinger's present address is Novartis Pharma AG, CH-4056 Basel, Switzerland.
###end p 2
###begin p 3
F.C. Kurschus's present address is I. Medizinische Klinik und Poliklinik, Johannes Gutenberg Universitat, D-55131 Mainz, Germany.
###end p 3
###begin p 4
###xml 192 193 192 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sup>
###xml 38 53 <span type="species:ncbi:10090">transgenic mice</span>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 635 639 <span type="species:ncbi:10090">mice</span>
###xml 646 661 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
We describe new T cell receptor (TCR) transgenic mice (relapsing-remitting [RR] mice) carrying a TCR specific for myelin oligodendrocyte glycoprotein (MOG) peptide 92-106 in the context of I-As. Backcrossed to the SJL/J background, most RR mice spontaneously develop RR experimental autoimmune encephalomyelitis (EAE) with episodes often altering between different central nervous system tissues like the cerebellum, optic nerve, and spinal cord. Development of spontaneous EAE depends on the presence of an intact B cell compartment and on the expression of MOG autoantigen. There is no spontaneous EAE development in B cell-depleted mice or in transgenic mice lacking MOG. Transgenic T cells seem to expand MOG autoreactive B cells from the endogenous repertoire. The expanded autoreactive B cells produce autoantibodies binding to a conformational epitope on the native MOG protein while ignoring the T cell target peptide. The secreted autoantibodies are pathogenic, enhancing demyelinating EAE episodes. RR mice constitute the first spontaneous animal model for the most common form of multiple sclerosis (MS), RR MS.
###end p 4
###begin p 5
Autoimmune diseases can affect most organs of the body including liver, heart, the endocrine system, the musculoskeletal apparatus, and the central nervous system (CNS). They commonly start off at a young age and then last throughout life, often resulting in severe disability. The factors that trigger the onset, modulate the course, and determine the clinical character of autoimmune diseases have remained obscure, a deficit of knowledge which sets limits to the design of specific and efficient therapies.
###end p 5
###begin p 6
Yet there is increasing evidence that organ-specific autoimmune diseases, such as rheumatoid arthritis, type 1 diabetes mellitus, and multiple sclerosis (MS), are the result of a pathogenic interaction of autoimmune T and B cells. There is substantial information on the role of T cells in organ-specific autoimmunity. Some act as effector cells attacking self-tissues, either directly or via recruiting accessory cells like macrophages. Other T cells regulate the time course of the response and still others provide help to autoantibody-producing B cells. The contribution of autoimmune B cells to the inflammatory pathogenesis seems to be complex as well. Beyond producing humoral autoantibodies, B cells serve as APCs activating pathogenic T cells, and, through their capacity of releasing cytokines, B cells are involved in shaping local microenvironments favorable to evolving cellular autoimmune responses.
###end p 6
###begin p 7
###xml 294 295 294 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 474 475 474 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 761 762 761 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 1082 1083 1082 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 352 357 <span type="species:ncbi:10090">mouse</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 567 571 <span type="species:ncbi:10090">mice</span>
###xml 749 754 <span type="species:ncbi:9606">human</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
Deciphering the interactions between T and B cells in the spontaneous development of organ-specific autoimmune responses requires suitable animal models. Naturally occurring models are available for type 1 diabetes mellitus and systemic lupus erythematosus but not for autoimmunity in the CNS (1). Recently, we and others described a double-transgenic mouse model, which simulates opticospinal MS (OSMS) remarkably well, a variant of which is also known as Devic's disease (2, 3). These mice, termed opticospinal experimental autoimmune encephalomyelitis (EAE [OSE]) mice, express myelin oligodendrocyte glycoprotein (MOG)-specific receptors on T and B cells and spontaneously develop demyelinating inflammatory disease at frequencies >50%. Like in human OSMS (4), the lesions in affected mice are restricted to optic nerve and spinal cord, and, in most cases, the disease takes a chronic progressive course without remissions and marked relapses. It should, however, be noted that the type of MS that most prevalently affects Caucasian populations differs fundamentally from OSMS (5). Typically, MS starts out with a relapsing-remitting (RR) course, where disease episodes may completely resolve only to be followed by a subsequent relapse. In this disease variant, the pathogenic lesions, demyelinating plaques, may be located throughout the CNS, thus causing the notoriously varied neurological defect patterns.
###end p 7
###begin p 8
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
In this paper, we describe a new transgenic mouse model that spontaneously develops RR-EAE and, thus, recapitulates the "Western" variant of MS. Furthermore, and most importantly, we found that in these mice transgenic autoimmune T cells expand autoimmune B cells from the endogenous immune repertoire and guide them to produce antibodies against conformational epitopes of the MOG protein, which, together with complement, may initiate the destruction of MOG-expressing target cells.
###end p 8
###begin title 9
RESULTS
###end title 9
###begin title 10
###xml 38 42 <span type="species:ncbi:10090">mice</span>
New MOG-specific TCR transgenic SJL/J mice
###end title 10
###begin p 11
###xml 113 114 113 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sup>
###xml 221 222 214 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 414 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 421 422 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 426 427 412 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 482 490 468 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 518 522 504 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 555 556 541 542 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 559 560 545 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 648 652 634 638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 687 691 673 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 698 706 684 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 13 28 <span type="species:ncbi:10090">transgenic mice</span>
###xml 63 66 <span type="species:ncbi:10116">rat</span>
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
###xml 261 266 <span type="species:ncbi:10090">mouse</span>
###xml 297 300 <span type="species:ncbi:10116">rat</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 653 657 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 733 738 <span type="species:ncbi:10090">mouse</span>
We generated transgenic mice expressing a TCR specific for the rat/mouse MOG peptide 92-106 in the context of I-As. This TCR, which uses Valpha8.3 and Vbeta4 genes, was derived from a MOG-specific encephalitogenic Th1-CD4+ T cell clone isolated from a WT SJL/J mouse immunized against recombinant rat MOG (rMOG; ). We selected three founder lines differing in markedly distinct proportions of transgenic Valpha8.3+/Vbeta4+ CD4+ T cells in central and peripheral immune repertoires (Fig. 1 A and ). In low frequency TCR1586 mice, 18% of single-positive CD4+CD8- thymocytes expressed the transgenic TCR. The proportion was 75% in medium frequency TCR1639 mice and 99% in high frequency TCR1640 mice (Fig. 1 A). In all three transgenic mouse lines, transgene expression levels in the peripheral immune system were proportional to the ones in the central thymic repertoires (Fig. S2).
###end p 11
###begin p 12
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Characterization of a new MOG-specific TCR transgenic SJL/J mouse.</bold>
###xml 389 390 375 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 394 395 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 402 403 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 408 409 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 506 507 492 493 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 658 664 644 650 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">92-106</sub>
###xml 899 903 885 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 905 906 891 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 915 919 901 905 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 921 922 907 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 931 935 917 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 937 938 923 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 949 950 935 936 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 103 118 <span type="species:ncbi:10090">transgenic mice</span>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 555 570 <span type="species:ncbi:10090">transgenic mice</span>
Characterization of a new MOG-specific TCR transgenic SJL/J mouse. (A) Thymocytes from 8-10-wk-old TCR transgenic mice or NTLs were stained with antibodies to CD4, CD8, TCR-Vbeta4, and TCR-Valpha8.3 and cells were analyzed by flow cytometry. Representative figures of three to seven analyzed mice are shown. Transgenic Valpha8.3 and Vbeta4 are shown on cells gated as indicated, either CD4+/CD8- or CD4-/ CD8+. (B) Proliferative response to recombinant MOG protein (rMOG) or MOG peptide 92-106 measured as 3H-thymidine incorporation. Splenocytes from TCR transgenic mice (8-10-wk-old healthy) were cultured with indicated concentrations of rMOG (top) and MOG92-106 (bottom). (C) Cytokine responses to rMOG. Indicated cytokines were measured in supernatants harvested 48 h after rMOG activation by ELISA. Pooled data from three independent experiments are shown. Error bars indicate SEM. B and C: TCR1640, n = 3; TCR1639, n = 3; TCR1586, n = 3; NTL, n = 2.
###end p 12
###begin p 13
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
The density of the transgenic TCR on the surface of mature CD4+ T cells in the spleen varied markedly (Fig. S2). Especially in high frequency TCR1640 spleens, T cells could be distinguished based on the low and high densities of surface TCR (dim and bright TCR). The dim TCR population expressed higher levels of CD25 and CD69 and lower levels of CD62L (unpublished data).
###end p 13
###begin p 14
###xml 68 74 68 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">92-106</sub>
###xml 139 147 139 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 330 334 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 342 346 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 386 390 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 482 490 478 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
Stimulation of nonimmunized transgenic spleen cells with rMOG or MOG92-106 peptide in vitro led to dose-dependent proliferative responses (Fig. 1 B). Concomitant cytokine responses largely followed the proliferation pattern. Although the secretion of proinflammatory IFN-gamma, IL-17, and antiinflammatory IL-10 was similar in TCR1640 and TCR1639 lines, IL-2 secretion was higher in TCR1639 T cells. The Th2-related cytokines IL-4 and IL-5 were absent in nearly all samples tested (Fig. 1 C).
###end p 14
###begin title 15
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Spontaneous EAE in single- and double-transgenic SJL/J anti-MOG mice: RR course with varied clinical syndromes
###end title 15
###begin p 16
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 146 154 146 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 414 418 414 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 448 452 448 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 457 461 457 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
While continuously backcrossing the line TCR1640 into the SJL/J background, we noted spontaneous EAE-like disease developing at a high frequency (Fig. 2 A and ). In the eighth backcross generation, >80% of all females developed EAE within 160 d. During the same period, the EAE rate in males was >60%. EAE was rare in transgenic SJL/J mice with low frequency TCR1586 and surprisingly absent in medium frequency TCR1639 mice and in Mog-deficient TCR1640 (TCR1640 x Mog-/-) mice (Table S1).
###end p 16
###begin p 17
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spontaneous RR-EAE in TCR transgenic SJL/J mice.</bold>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 130 134 130 134 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 140 143 140 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 247 251 247 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 284 288 284 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 315 319 315 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 352 353 352 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 363 367 363 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 373 376 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 386 387 386 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 401 402 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 419 422 419 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 422 425 422 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 472 476 472 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 575 579 575 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 585 588 585 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 679 683 679 683 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 144 148 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 684 689 <span type="species:ncbi:10090">mouse</span>
###xml 694 699 <span type="species:ncbi:10090">mouse</span>
###xml 1265 1269 <span type="species:ncbi:10090">mice</span>
Spontaneous RR-EAE in TCR transgenic SJL/J mice. (A) Male and female single-transgenic TCR1640 compared with double-transgenic TCR1640 x IgHMOG mice. Shown is the spontaneous incidence of first signs of ataxia or classical EAE-like symptoms in TCR1640 (left) and double-transgenic TCR1640 x IgHMOG (right) mice. TCR1640 females (f), n = 12; males (m), n = 27; TCR1640 x IgHMOG females, n = 20; males, n = 26; TCR1640 x Mog-/- mice, n = 6. Disease kinetic of genders in TCR1640 mice was not statistically significant (P = 0.304) but differed significantly between sexes of TCR1640 x IgHMOG mice (P = 0.0004). (B) Histological analysis of cerebellum and spinal cord from a sick TCR1640 mouse (RR mouse) with ataxia and classical paralysis. Cerebellum (I-IV) and spinal cord (V-VIII) showed severe infiltration, demyelination, and axonal damage as visualized by immunohistochemistry using anti-CD3 (I and V) and anti-Mac3 antibodies (II and VI), Luxol fast blue staining (III and VII), and Bielschowsky silver impregnation (IV and VIII). I, II, V, and VI were counterstained by hematoxylin and eosin (H&E). Magnification: x17 (cerebellum) and x30 (spinal cord). Bars, 1 mm. Data are representative of at least two independent experiments consisting of more than three mice per group.
###end p 17
###begin p 18
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 185 186 185 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 313 316 313 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 324 325 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 392 396 392 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 460 464 460 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 524 528 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 363 378 <span type="species:ncbi:10090">transgenic mice</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
We and others previously described a double-transgenic mouse strain, OSE mice (2, 3), which expressed a MOG-specific TCR transgene, 2D2 (specific for MOG peptide 35-55 in context of I-Ab), along with the gene coding for the rearranged IgH variable chain of the classical anti-MOG monoclonal antibody, 8.18-C5 (IgHMOG mice) (6). We have now created similar double-transgenic mice by mating TCR1640 SJL/J mice to IgHMOG on SJL/J background. Double-transgenic TCR1640 x IgHMOG mice developed spontaneous EAE very similar to TCR1640 single transgenics, with some apparently minor differences. Almost all double-transgenic females came down with disease by 120 d of age, whereas males of the same age showed an EAE rate of <40%. This gender gap was highly significant but narrowed during the subsequent weeks (Fig. 2 A).
###end p 18
###begin p 19
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 138 142 138 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 204 208 204 208 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
We also crossed IgHMOG mice to the medium and low frequency lines TCR1639 and TCR1586, respectively. Only 1 out of 17 medium frequency TCR1639 x IgHMOG mice displayed EAE and none of the low frequency TCR1586 x IgHMOG showed any clinical symptoms (Table S1).
###end p 19
###begin p 20
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 189 193 189 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 235 238 235 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 1118 1125 1118 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 194 198 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
The CNS disease spontaneously developing in TCR transgenic SJL/J mice differed dramatically from spontaneous OSE seen in OSE mice (2, 3). In TCR transgenic SJL/J mice, single-transgenic TCR1640 mice, and double-transgenic TCR1640 x IgHMOG mice, disease was extremely variable both in course and clinical nature. Typically, in females EAE started with an RR course. Often, the first attacks resolved completely but were followed by further bouts. Intriguingly, individual EAE bouts often differed radically in their neurological defects. In a substantial number of cases, the initial bout was dominated by ataxia rather than by classical EAE defects. Affected mice were unable to walk along a straight line, deviating and falling to the side, but did not show limb weakness or paralysis (). In many cases, the mice recovered completely until a first relapse, which commonly showed a completely different clinical picture, for example, hind limb paralysis as seen in typical EAE. Again, this second disease episode subsided, giving way to partial remission. Later disease episodes mostly showed classical paralytic EAE (Table I and ).
###end p 20
###begin p 21
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Spontaneous EAE in TCR transgenic SJL/J mice: course of disease
###end p 21
###begin p 22
f, female; m, male; imm., immunized.
###end p 22
###begin p 23
###xml 152 159 152 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table I</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
Although there was no clear distinction between single- and double-transgenic SJL/J mice, EAE course differed between females and males. As detailed in Table I, RR disease was more common in females. A minority of female mice developed progressive EAE from the beginning, but more than half of the males developed primary progressive EAE.
###end p 23
###begin title 24
CNS changes representing different clinical EAE episodes
###end title 24
###begin p 25
###xml 222 230 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 133 137 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
The clinical deficiencies developing in affected mice were reflected by the location and character of underlying CNS lesions. Ataxic mice displayed large inflammatory and demyelinated lesions in cerebellum and brain stem (Fig. 2 B). In contrast, in mice suffering from conventional EAE, lesions were distributed throughout the spinal cord, brain stem, and optic nerve ().
###end p 25
###begin p 26
###xml 106 107 106 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 398 402 398 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 428 432 428 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 449 464 <span type="species:ncbi:10090">transgenic mice</span>
Irrespective of their location within the CNS, the inflammatory lesions were characterized by numerous CD3+ T cells in the middle of a plethora of Mac3-positive activated macrophage-like cells (Fig. 2 B). The inflammatory infiltrates were embedded in large areas of demyelination and axon destruction. In line with their comparable clinical score, the histological patterns were similar between TCR1640 single-transgenic and TCR1640 x IgHMOG double-transgenic mice (Table S2).
###end p 26
###begin p 27
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 191 192 191 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 202 213 202 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3, A&#8211;C</xref>
###xml 254 255 254 255 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 413 421 413 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 454 455 454 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 833 834 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 850 858 843 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
Cytofluorimetric analyses confirmed that, within the CNS, the major infiltrating inflammatory lymphocytes were CD4+ T cells and B cells together with a minor population of macrophages and CD8+ T cells (Fig. 3, A-C), with only minor contributions from CD8+ T cells. Notably, most transgenic CD4+ T cells infiltrating the CNS were activated. Many cells expressed the activation marker CD25 and were CD62L negative (Fig. 3 D). Additionally, infiltrating CD4+ T cells expressed the activation markers CD44, VLA4, and ICOS (unpublished data). Furthermore, a high proportion (>65%) of CNS-infiltrating transgenic T cells partly down-modulated their transgenic Vbeta4 and Valpha8.3 determinants, which is in contrast to peripheral splenic populations, where the modulated subpopulations comprised less than half of the entire transgenic CD4+ T cell subset (Fig. 3 E).
###end p 27
###begin p 28
###xml 0 48 0 48 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Inflammatory cell infiltrates in RR-EAE lesions.</bold>
###xml 99 103 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 220 224 220 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 388 389 388 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 394 395 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 498 499 498 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 741 742 734 735 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 745 746 738 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 787 791 780 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 910 913 896 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">low</sup>
###xml 1131 1132 1113 1114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1138 1139 1120 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1160 1161 1138 1139 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1167 1168 1145 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1219 1223 1197 1201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1304 1305 1282 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1308 1309 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1381 1385 1359 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 104 108 <span type="species:ncbi:10090">mice</span>
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
###xml 792 796 <span type="species:ncbi:10090">mice</span>
###xml 1236 1240 <span type="species:ncbi:10090">mice</span>
###xml 1386 1390 <span type="species:ncbi:10090">mice</span>
Inflammatory cell infiltrates in RR-EAE lesions. (A-C) Cellular infiltrate into the CNS of sick TCR1640 mice (score 3) is composed of macrophages, T cells, and B cells. CNS mononuclear cells were isolated from a sick TCR1640 mouse and stained against CD11b and CD45.1 (A), together with CD8 and CD4 (B) or together with CD19 and B220 (C). Cells in B and C were analyzed among gated CD45.1+CD11b- cells (red region as indicated). (D-F) Activation and Th1/Th17 cytokine expression of infiltrating CD4+ T cells. (D) CNS infiltrate cells express CD25, but not CD62L, and partially down-modulate their TCR (Valpha8.3 and Vbeta4). Activation status and TCR expression was compared between splenocytes (left) and CNS-isolated cells (right). (E) CD4+CD3+ T cells infiltrating the CNS of sick TCR1640 mice predominantly expressed the pathogenic TCR composed of Valpha8.3 and Vbeta4 chains in a low expression level (TCRlow) compared with the spleen. Numbers indicate the percentage of stained cells in the respective quadrant or region. (F) Intracellular cytokine staining after stimulation with PMA/ionomycin in brefeldin A. Th1 (IFN-gamma+/IL-17-) and Th17 (IFN-gamma-/IL-17+) cells are enriched in CNS infiltrates of sick TCR1640 (score 3.5) mice compared with splenocytes. D-F were analyzed among gated CD45.1+CD4+ cells. Flow cytometry data are representative of three to five sick TCR1640 mice analyzed in three to five independent experiments.
###end p 28
###begin p 29
###xml 40 41 40 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 87 88 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 94 95 90 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 116 117 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 123 124 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 230 238 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
###xml 280 281 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 285 286 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 389 391 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
In agreement with previous EAE studies (7-10), we found CNS-infiltrating Th1 (IFN-gamma+/IL-17-) and Th17 (IFN-gamma-/IL-17+) cells. Compared with spleen, Th17 cells were enriched in CNS threefold and Th1 cells more than twofold (Fig. 3 F). A substantial part of the activated CD4+CD25+ infiltrate T cells express transcription factor Foxp3, a marker of regulatory T cells (not depicted) (11).
###end p 29
###begin p 30
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 293 299 293 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 676 678 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 918 922 906 910 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1334 1338 1322 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1578 1582 1566 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 162 166 <span type="species:ncbi:10090">mice</span>
###xml 362 366 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 923 927 <span type="species:ncbi:10090">mice</span>
###xml 1018 1022 <span type="species:ncbi:10090">mice</span>
###xml 1162 1166 <span type="species:ncbi:10090">mice</span>
###xml 1239 1243 <span type="species:ncbi:10090">mice</span>
###xml 1259 1263 <span type="species:ncbi:10090">mice</span>
###xml 1339 1343 <span type="species:ncbi:10090">mice</span>
###xml 1410 1414 <span type="species:ncbi:10090">mice</span>
###xml 1583 1587 <span type="species:ncbi:10090">mice</span>
Next, we measured the cytokine milieu in brain and spinal cord of TCR1640 mice in different disease stages by real-time PCR in comparison to rMOG immunized SJL/J mice (). Most cytokines followed an infiltration pattern proportional to CD4 expression. As expected from our infiltrate analysis (Fig. 3), we found expression of both IFN-gamma and IL-17 in diseased mice. In accordance with this, TNF-alpha and IFN-gamma inducible protein 10 (IP-10/CXCL10) were strongly up-regulated during disease. Of the Th2 cytokines analyzed (IL-4, IL-5, and IL-13), only IL-5 was at measurable levels. This cytokine may support B cell proliferation, differentiation, and antibody secretion (12). The levels of the regulatory cytokine IL-10 and of the T reg cell transcription factor FoxP3 paralleled the observed expression of CD4 in diseased mice. Interestingly, we found no major differences between immunized WT SJL/J mice and TCR1640 mice, which suffered from classical paralytic EAE. In line with their clinical picture, ataxic mice showed higher expression levels of the analyzed genes in brain (which also includes cerebellum and brain stem) than did paralytic relapsed mice. Conversely, expression in spinal cord was higher in paralytic relapsed mice than in ataxic mice. Intriguingly, most analyzed factors were elevated even in healthy TCR1640 mice (score 0) as compared with healthy nontransgenic littermate (NTL) mice, likely indicating subclinical inflammation. Finally, during the remission phase, expression of all analyzed genes dropped down to similar values as in score 0-TCR1640 mice (Fig. S4).
###end p 30
###begin title 31
###xml 40 44 40 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Expansion of MOG-specific B cells in TCR1640 single-transgenic SJL/J mice
###end title 31
###begin p 32
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 137 141 137 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 216 222 216 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 293 294 293 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 453 459 453 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 464 472 464 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Single-transgenic TCR1640 mice showed evidence of a strong MOG-specific B cell response. Spontaneous EAE lesions of single-transgenic TCR1640 animals displayed prominent deposits of Ig and some activated complement (Fig. 4). Furthermore, the inflamed CNS tissue contained, besides CD4+ and CD8+ lymphocytes, substantial numbers of B cells (5-40% of infiltrated lymphocytes) expressing CD19 or B220 as revealed by immunocytochemistry and flow cytometry (Fig. 3 and Fig. 4 E).
###end p 32
###begin p 33
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ig deposition and B cell infiltrates in spinal cord of sick TCR<sup>1640</sup> &#215; IgH<sup>MOG</sup> and TCR<sup>1640</sup> mice.</bold>
###xml 197 201 197 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 207 210 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 228 232 228 232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 403 407 403 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 474 478 474 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 243 247 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 479 483 <span type="species:ncbi:10090">mice</span>
###xml 729 733 <span type="species:ncbi:10090">mice</span>
Ig deposition and B cell infiltrates in spinal cord of sick TCR1640 x IgHMOG and TCR1640 mice. (A-D) Histological analysis of spinal cord using anti-Ig antibodies shows deposition of Ig in sick TCR1640 x IgHMOG (A and B) and TCR1640 (C and D) mice (B and D show magnifications of marked areas in A and C, respectively). (E) Anti-B220 staining revealed some B cells among cellular infiltrates in sick TCR1640 mice. (F) Deposition of complement C9neo within CNS lesions of TCR1640 mice. Mononuclear cells were stained with H&E. Magnifications: A and C, x50; B, x425; D and E, x200; F, x450. Bars: (A and C) 1 mm; (B and D-F) 100 microm. Data are representative of at least two independent experiments consisting of more than three mice per group.
###end p 33
###begin p 34
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh<sup>a</sup></italic>
###xml 239 240 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh<sup>b</sup></italic>
###xml 251 259 251 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 316 331 316 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and B</xref>
Double-transgenic TCR1640 x IgHMOG animals showed an anti-MOG antibody response dominated by the transgene-specific allotype Igha. In addition, however, a minor part of the MOG-specific antibodies expressed the endogenous nontransgenic Ighb allotype (Fig. 5 B). Both antibody species were switched from IgM to IgG1 (Fig. 5, A and B).
###end p 34
###begin p 35
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG-specific antibodies in double-transgenic TCR<sup>1640</sup> &#215; IgH<sup>MOG</sup> and single TCR transgenic mice.</bold>
###xml 119 120 119 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 251 252 251 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 270 274 270 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 282 286 282 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 292 295 292 295 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 77 92 <span type="species:ncbi:10090">transgenic mice</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
MOG-specific antibodies in double-transgenic TCR1640 x IgHMOG and single TCR transgenic mice. (A) MOG binding allotype a autoantibodies were detected by ELISA in sera of indicated groups (each five to six mice). (B) Spontaneous anti-MOG IgG1 allotype b antibodies in TCR1640 and TCR1640 x IgHMOG but not in NTL (n = 5 for each group). Sera at the indicated dilutions were incubated with plates precoated with rMOG. Bound anti-MOG Ig was detected by allotype-specific antibodies as indicated. Mean absorbance at OD 405 nm is shown. Error bars indicate SEM. Data are representative of two to three independent experiments.
###end p 35
###begin p 36
###xml 21 25 21 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 87 88 87 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Igh<sup>b</sup></italic>
###xml 166 174 166 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 324 328 324 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 446 450 446 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 567 575 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 635 639 635 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 810 814 810 814 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 833 836 833 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 848 851 848 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 851 854 851 854 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 878 880 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 928 936 928 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 965 969 965 969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1037 1045 1037 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 1072 1076 1072 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1286 1294 1286 1294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 584 588 <span type="species:ncbi:10090">mice</span>
###xml 815 819 <span type="species:ncbi:10090">mice</span>
###xml 970 974 <span type="species:ncbi:10090">mice</span>
###xml 1077 1081 <span type="species:ncbi:10090">mice</span>
###xml 1212 1216 <span type="species:ncbi:10090">mice</span>
Single-transgenic TCR1640 mice also produced anti-MOG autoantibodies (of endogenous Ighb-allotype) reaching titers similar to those from WT mice immunized with rMOG (Fig. 6 A). The anti-MOG Igs were mainly of IgG1 and IgG2a/b isotypes, with very little IgM. The spontaneously appearing anti-MOG transgenic high frequency TCR1640 mice formed autoantibodies irrespective of their EAE status. This contrasted with low frequency single-transgenic TCR1586, where anti-MOG autoantibodies were noted solely in the few animals with spontaneous EAE but not in resistant mice (Fig. 6 B). Also, mice of the EAE-resistant medium frequency line TCR1639 did not produce spontaneous MOG-specific antibodies. Development of spontaneous MOG antibodies was dependent on the presence of the autoantigen. Sera of MOG-deficient TCR1640 mice (bred on the Mog-deficient [Mog-/-] background [reference 13]) did not contain any MOG-specific antibodies (Fig. 6 B). The B cell response in TCR1640 mice was specific to MOG and did not extend to other autoantigens (Fig. 6 C). In single-transgenic TCR1640 mice, autoantibodies became demonstrable from 5 wk of life and, in our series of measurements, persisted up to 9-10 wk, but very young mice, up to 4 wk of age, had no anti-MOG Igs (IgG1 and IgG2a/b isotypes) (Fig. 6 D).
###end p 36
###begin p 37
###xml 0 54 0 54 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG-specific antibodies in single TCR transgenic mice.</bold>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 167 171 167 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 249 250 249 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 276 280 276 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 293 297 293 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 312 316 312 316 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 323 327 323 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 391 394 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 394 397 394 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 513 517 513 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 658 662 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 693 694 693 694 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 755 756 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 768 769 768 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 776 780 776 780 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 38 53 <span type="species:ncbi:10090">transgenic mice</span>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 518 522 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
###xml 781 785 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 914 918 <span type="species:ncbi:10090">mice</span>
MOG-specific antibodies in single TCR transgenic mice. (A) Endogenous MOG binding antibodies of allotype b were measured by ELISA in sera of NTLs, healthy and sick TCR1640, and rMOG-immunized WT SJL/J (n = 6 for each group). (B) Anti-MOG Igs of IgG1b isotype are formed in TCR1640 and sick TCR1586 but not in TCR1639 or TCR1586 mice. Control NTLs, as well as TCR1640 mice deficient for MOG (Mog-/-), are devoid of MOG binding autoantibodies (each three to five mice per group). (C) Autoantibodies in sera from TCR1640 mice are specific for MOG. Anti-MOG Ig antibodies, but not anti-MBP or anti-DNA-specific antibodies, were detected by ELISA in sera from TCR1640 mice (1/50 diluted) using IgG1b-specific antibodies (n = 5). (D) Appearance of anti-MOG IgG1b and IgG2a/bb in TCR1640 mice by 5 wk of age. MOG binding antibodies were measured in 1/100 diluted sera from mice of different ages, each with three to five mice per group. Sera at the indicated dilutions were incubated with plates precoated with rMOG. Bound anti-MOG Ig was detected by allotype-specific antibodies as indicated. Mean absorbance at OD 405 nm is shown. Error bars indicate SEM. Data are representative of two independent experiments.
###end p 37
###begin title 38
Contribution of endogenous B cells and anti-MOG autoantibodies to RR spontaneous EAE
###end title 38
###begin p 39
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 525 529 525 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 535 538 535 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 545 547 545 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 550 558 550 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 595 599 595 599 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 612 616 612 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 700 708 700 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 783 787 783 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1586</sup>
###xml 795 799 795 799 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1639</sup>
###xml 803 806 803 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 820 824 820 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 166 170 <span type="species:ncbi:10090">mice</span>
###xml 188 192 <span type="species:ncbi:10090">mice</span>
###xml 261 264 <span type="species:ncbi:31658">CFA</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
###xml 681 687 <span type="species:ncbi:9986">rabbit</span>
There is evidence that only autoantibodies directed against conformational epitopes, not linear epitopes, are involved in the pathogenesis of EAE (14) and that SJL/J mice, but not C57BL/6 mice, are able to produce such antibodies upon immunization with rMOG in CFA (15). The anti-MOG autoantibodies formed spontaneously in TCR1640 mice also bound to correctly folded MOG expressed on the surface of transduced EL4 cells and, thus, behaved like the classical anticonformational MOG mAb 8.18-C5 and its H chain transgene in TCR1640 x IgHMOG mice (16) (Fig. 7 A). Binding of autoantibodies from TCR1640 and sick TCR1586 mice to EL4-MOG cells (dilutions of 1:20 and 1:200) followed by rabbit complement (Fig. 7 B) resulted in the specific lysis of the target cells. Sera from healthy TCR1586 and TCR1639 or Mog-deficient TCR1640 did not support lysis (unpublished data).
###end p 39
###begin p 40
###xml 0 78 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG-specific autoantibodies bind MOG-expressing cells and activate complement.</bold>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 357 361 <span type="species:ncbi:10090">mice</span>
###xml 670 685 <span type="species:ncbi:10090">transgenic mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 971 977 <span type="species:ncbi:9986">rabbit</span>
MOG-specific autoantibodies bind MOG-expressing cells and activate complement. (A) Binding of anti-MOG Ig from indicated mice to correctly conformed MOG on the cell surface of transduced EL4 cells (EL4-MOG) shown by flow cytometry. EL4 cells (top) and MOG-expressing EL4-MOG cells (bottom) were incubated with 1/200 diluted sera obtained from the indicated mice or 0.5 microg/ml 8.18-C5 mAb. Bound antibodies were detected by FACS using biotinylated anti-IgG1-specific antibody (allotype unspecific) and streptavidin-PE (SA-PE). A representative plot of three independent experiments is shown. (B) Complement activating capability of MOG binding antibodies in sera from transgenic mice. EL4 and EL4-MOG cells were incubated with sera (1/20 and 1/200 diluted) obtained from the indicated mice, each with three to five per group. Complement activating capability was measured by cell lysis using propidium iodide (PI) staining after incubation of sera-bound EL4 cells with rabbit complement. Background values were subtracted, and shown are mean values with the SEM of one experiment representative of three similar experiments.
###end p 40
###begin p 41
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 411 415 411 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 A</xref>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 385 389 <span type="species:ncbi:10090">mice</span>
We confirmed the pathogenic potential of antibodies, in vivo. We immunized WT SJL/J mice with a low dose of PLP 139-151 and with incipient clinical EAE symptoms (between scores 0.5 and 1), we transferred serum either from TCR1640 mice (high titers of anti-MOG antibodies documented by ELISA) or NTLs, and compared the effects with the standard anti-MOG monoclonal antibody 8.18C-5. In mice that had received TCR1640 serum, we noted a statistically significant increase in EAE severity similar to that of 8.18C-5 mAb (Fig. 8 A).
###end p 41
###begin p 42
###xml 0 66 0 66 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B cells and anti-MOG antibodies are essential for spontaneous EAE.</bold>
###xml 131 135 131 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 253 257 253 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 362 366 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 647 651 647 651 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 709 713 709 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1027 1031 1027 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 1147 1151 1147 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 196 200 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 652 656 <span type="species:ncbi:10090">mice</span>
###xml 714 718 <span type="species:ncbi:10090">mice</span>
###xml 806 810 <span type="species:ncbi:10090">mice</span>
###xml 820 825 <span type="species:ncbi:10090">mouse</span>
###xml 953 957 <span type="species:ncbi:10090">mice</span>
###xml 1032 1036 <span type="species:ncbi:10090">mice</span>
###xml 1152 1156 <span type="species:ncbi:10090">mice</span>
B cells and anti-MOG antibodies are essential for spontaneous EAE. (A) Spontaneously developed MOG-specific autoantibodies from TCR1640 mice have pathogenic potential. EAE was induced in WT SJL/J mice by low-dose PLP 139-151 immunization. Serum from TCR1640 mice, NTL mice, or 8.18c5 mAb were transferred after mice showed first clinical symptoms. Serum from TCR1640 mice significantly increased disease severity in recipient mice compared with serum from NTL mice. Error bars indicate SEM. *, P < 0.05; **, P < 0.01; ***, P < 0.001. Data were pooled from two independent experiments, each six to seven per group. (B) B cell depletion protects TCR1640 mice from spontaneous EAE. B cells were depleted from TCR1640 mice by twice weekly injections of anti-CD20 antibodies from day 3 after birth, and control mice received mouse IgG2a antibodies. The development of spontaneous EAE was monitored regularly. Although 85% of isotype control antibody-treated mice developed spontaneous EAE, treatment with CD20 antibody protected TCR1640 mice from disease development. Shown are the disease course (left) and the spontaneous EAE incidence (right) of TCR1640 mice treated with these antibodies. Data were pooled from two independent experiments, each with six to seven per group.
###end p 42
###begin p 43
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 166 170 166 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 B</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 131 136 <span type="species:ncbi:10090">mouse</span>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 224 229 <span type="species:ncbi:10090">mouse</span>
###xml 622 626 <span type="species:ncbi:10090">mice</span>
###xml 681 685 <span type="species:ncbi:10090">mice</span>
To examine the importance of B cells in the development of spontaneous EAE, we depleted B cells in TCR1640 mice using a monoclonal mouse anti-mouse CD20 antibody. TCR1640 mice were treated with anti-CD20 or isotype control (mouse IgG2a) every 2 wk starting on day 3. This protocol removed the B cells from peripheral blood, as well as spleen and lymph nodes, but left significant numbers of B cells in the bone marrow (). B cell depletion went along with either complete or partial loss of anti-MOG IgG1 serum autoantibodies (Fig. S5 C). Within an observation period of up to 30 wk, only one out of nine anti-CD20-treated mice presented mild and transient EAE symptoms, whereas in mice receiving control antibody, spontaneous EAE was noted in >85% of the cases (Fig. 8 B and ).
###end p 43
###begin title 44
DISCUSSION
###end title 44
###begin p 45
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 153 158 <span type="species:ncbi:9606">human</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
The RR mouse, as described in this paper, is the first transgenic mouse model that recapitulates the major features of RR-MS, the most prevalent type of human inflammatory demyelination. The disease starts spontaneously and, in contrast to OSE mice described previously (2, 3), in most cases takes an RR course, with clinical signs differing between individual bouts. Importantly, development of spontaneous disease goes along with the expansion of myelin autoimmune B cells from the endogenous immune repertoire.
###end p 45
###begin title 46
Spontaneous RR-EAE
###end title 46
###begin p 47
###xml 122 123 122 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sup>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 3 7 <span type="species:ncbi:10090">mice</span>
###xml 29 33 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 195 199 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
RR mice are transgenic SJL/J mice expressing at high frequency a TCR specific for MOG peptide 92-106 in the context of I-As. RR mice differ substantially from previously created transgenic SJL/J mice expressing TCRs recognizing a dominant peptide of PLP (17). These animals, kept under specific pathogen-free conditions, developed spontaneous disease but, in contrast to RR mice, the disease was mostly progressive without remissions and subsequent relapses.
###end p 47
###begin p 48
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 449 453 <span type="species:ncbi:10090">mice</span>
###xml 503 507 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
The course and clinical expression of autoimmune diseases are determined by diverse factors, both genetic and environmental. Indeed, SJL/J mice are predisposed to develop fluctuating disease. Depending on the protocol applied, active immunization against encephalitogenic proteins may trigger RR disease (18). Clearly, this response pattern is facilitated by distinct regulatory genes (19), which may also influence spontaneous EAE developing in RR mice. So far, our breeding results suggest that B10.S mice, which have a distinct genetic background but share the MHC and the TCR transgene with SJL/J RR mice, very rarely develop spontaneous EAE, and in the few cases observed, the disease took a chronic rather than RR course (unpublished data).
###end p 48
###begin p 49
###xml 278 280 278 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 538 543 <span type="species:ncbi:10090">mouse</span>
Most variants of induced EAE present a stereotypical clinical syndrome with motor deficiencies starting at tail and hind limbs and progressing cranially with ongoing disease. Histologically, this clinical picture is reflected by a caudocranial gradient of inflammatory lesions (20). In a few models, however, additional parts of the CNS are affected. For example, in C57BL/6 mice, MOG-induced EAE has a predilection to affect the optic nerve (2, 3), and cerebellar disease was noted in further antigen/mouse combinations (21, 22). Our RR mouse models are the first to show immune attacks against different CNS parts in subsequent inflammatory relapses. They thus provide a unique paradigm to study the mechanisms underlying the targeting of MS lesions within the CNS during ongoing disease.
###end p 49
###begin p 50
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 624 626 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 847 851 <span type="species:ncbi:10090">mice</span>
Several investigators reported that in RR-EAE actively induced by immunization with encephalitogenic peptides, relapses went along with the T cell reactivity against new epitopes (23), a phenomenon termed "determinant spreading" by Lehmann et al. (24). Recent work by McMahon et al. (25) suggests that in actively induced chronic EAE, initial bouts of CNS inflammation result in the induction of professional APCs within or near the affected CNS target tissue. By taking up myelin antigens and presenting crucial epitope components to newly arrived naive autoreactive T cells, the repertoire of target autoantigens spreads (25). It should, however, be mentioned that determinant spreading, i.e., recruitment of potentially encephalitogenic T cells specific for epitopes other than MOG p92-106, has not been patent in spontaneous disease of our RR mice.
###end p 50
###begin title 51
Expansion of MOG-specific B cells from endogenous repertoire
###end title 51
###begin p 52
###xml 320 321 320 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 323 324 323 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
As described recently, in the C57BL/6 OSE model, MOG-reactive TCR transgenic T cells require the presence of MOG-specific B cells to kindle spontaneous EAE at high frequency. In this model, the MOG-specific B cells were transgenic with their germline IgJ region replaced by the rearranged H chain of a MOG-specific mAb (2, 3).
###end p 52
###begin p 53
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 66 81 <span type="species:ncbi:10090">transgenic mice</span>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 447 462 <span type="species:ncbi:10090">transgenic mice</span>
Based on these previous observations, we initially created double-transgenic mice by crossing our new MOG TCR transgenic SJL/J strain with MOG-specific B cell knock-in SJL/J mice. These mice presented with spontaneous RR-EAE at high frequency. Less expected spontaneous EAE was noted also in TCR single-transgenic SJL/J mice with a high proportion of MOG-reactive CD4 T cells but without transgenic B cells. It turned out that in these TCR single-transgenic mice, MOG-specific B cells were expanded from the endogenous B cell compartment. Substantial numbers of B cells were observed to invade the inflammatory lesions, and there were heavy local deposits of Ig along with some activated complement. Most importantly, TCR single transgenics produced high titers of anti-MOG autoantibodies of IgG1 and IgG2 isotypes, which bound to correctly conformed membrane bound autoantigen, destroyed MOG-expressing target cells, and, thus, have demyelinating potential (16).
###end p 53
###begin p 54
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
MOG-reactive B cells are essential for the spontaneous development of RR-EAE. Depletion of B cells by treatment with anti-CD20 mAb profoundly suppressed RR-EAE when started at young age. Treatment of adult mice produced much more inconsistent results, a phenomenon which was recently noted in other investigations in actively induced EAE (26).
###end p 54
###begin p 55
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 137 141 <span type="species:ncbi:10090">mice</span>
###xml 474 478 <span type="species:ncbi:10090">mice</span>
B cells contribute to immune and autoimmune responses by secreting humoral antibodies, by acting as APCs, and by releasing cytokines. RR mice, both single and double transgenic, produce MOG-specific autoantibodies that share their dominant isotype, IgG1, with the original demyelinating anti-MOG mAb 8.18-C5 and that, in vivo, aggravate EAE when transferred i.v. (27). Importantly, we found large Ig deposits in the demyelinating lesions of single- and double-transgenic RR mice. At least part of these antibodies may have been produced by local infiltrating B cells. In fact, B cells isolated from CNS infiltrates were found to secrete anti-MOG antibodies at high levels.
###end p 55
###begin p 56
###xml 173 177 173 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MOG</sup>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 583 585 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
Beyond autoantibody secretion, MOG-specific B cells profoundly influence autoimmune responses by directly interacting with autoimmune T cells. In OSE mice, as well as in TCR1640 x IgHMOG mice (unpublished data), MOG-specific B cells concentrate highly diluted MOG and present the antigen to MOG-reactive T cells. Hence, antigen-presenting B cells may contribute to the initiation and progression of spontaneous EAE. But, in addition, B cells may act into the opposite direction; they were shown to limit EAE by releasing IL-10 (28) and by influencing function of regulatory T cells (29).
###end p 56
###begin p 57
###xml 360 363 360 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 395 399 <span type="species:ncbi:10090">mice</span>
The spontaneous recruitment and expansion of autoimmune B cells from the endogenous repertoire by organ-specific autoimmune T cells in the absence of exogenous autoantigen represents a mechanism of autoimmunity that has not yet been described. The MOG-specific B cell expansion process critically requires the presence of the endogenous target autoantigen, as Mog-deficient TCR transgenic SJL/J mice never produced anti-MOG autoantibodies, nor did they develop spontaneous RR-EAE.
###end p 57
###begin p 58
###xml 389 390 389 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 256 271 <span type="species:ncbi:10090">transgenic mice</span>
The role of endogenous MOG is intriguing, considering that this target autoantigen is predominantly confined to the CNS tissues, which are largely inaccessible to circulating T and B cells. This hidden localization distinguishes the RR mouse paradigm from transgenic mice, where activation of virus-specific B cell was noted in the presence of high numbers of virus-specific transgenic CD4+ T cells and a viral pseudo-autoantigen expressed throughout the organism in cell types including DCs and macrophages (30).
###end p 58
###begin p 59
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 537 539 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 686 688 686 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 694 696 694 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 915 919 <span type="species:ncbi:10090">mice</span>
Several mechanisms could be involved in MOG-specific B cell expansion. MOG-specific T cells could intrude into the naive CNS and create immunogenic conditions that allow the activation and expansion of naive B cells in the local milieu. This scenario has been forwarded recently as an explanation of epitope spreading in actively induced EAE (25). Alternatively, immunogenic MOG and/or myelin debris could be transported to local lymph nodes, either as cell-free material or by phagocytes, to be presented there to autoreactive B cells (31). Although MOG is predominantly expressed in the CNS, its messenger RNA was also found in some non-CNS organs, such as thymus, spleen, and liver (13, 32, 33), and low protein levels were found in the peripheral nervous system (34). Presentation of very low amounts of peripherally available MOG remains, at least in theory, an alternative mechanism of B cell expansion in RR mice.
###end p 59
###begin p 60
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 237 242 <span type="species:ncbi:9606">human</span>
Finally, animal models with spontaneously developing EAE show promise for the discovery of new drugs and the validation of existing medications. Thus, the opticospinal type of EAE described previously may represent essential features of human OSMS/Devic's disease (2), a disease variant which is rarely found in high prevalence populations. The spontaneous RR-EAE, with its conspicuous variation of neurological deficiencies, will provide a model for the most frequent type of MS, as it is seen typically in early phases of the disease.
###end p 60
###begin title 61
MATERIALS AND METHODS
###end title 61
###begin title 62

###end title 62
###begin title 63
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 63
###begin p 64
###xml 59 62 59 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 208 212 208 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 6 10 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
###xml 231 235 <span type="species:ncbi:10090">mice</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
SJL/J mice were purchased from Charles River Laboratories. Mog KO mice (13) were backcrossed into SJL/J for seven generations, crossed with TCR1640 transgenic SJL/J mice, and then intercrossed to generate TCR1640 transgenic Mog KO mice. All mouse strains were bred in the animal facilities of the Max Planck Institute of Neurobiology (Martinsried, Germany).
###end p 64
###begin title 65
###xml 18 33 <span type="species:ncbi:10090">transgenic mice</span>
Generation of TCR transgenic mice.
###end title 65
###begin p 66
###xml 227 233 220 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">92-106</sub>
###xml 246 247 239 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">s</sup>
###xml 1639 1641 1588 1590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 1718 1719 1667 1668 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 112 117 <span type="species:ncbi:10090">mouse</span>
###xml 141 144 <span type="species:ncbi:31658">CFA</span>
###xml 2246 2261 <span type="species:ncbi:10090">Transgenic mice</span>
TCR donor clone (C3) was selected from a panel of MOG-specific T cell clones (series SL48) derived from a SJL/J mouse immunized with rMOG in CFA. The encephalitogenic clone C3 uses Valpha8.3 along with Vbeta4 and recognizes MOG92-106 bound to I-As. Total RNA of clone C3 was isolated by TRI reagent extraction (Sigma-Aldrich) and, after DNase I treatment, was converted into complementary DNA (cDNA) using hexanucleotide primers and Superscript II reverse transcription (Invitrogen). The rearranged cDNA of TCR-alpha8.3 and TCR-beta4 chains were amplified with the following primer pairs: TCR-alpha8.3 sense with SalI restriction site, 5'-AGGTGTCGACCTTCCATGAACATGCGTCCTGACACC-3'; TCR-alpha C terminus with BamHI restriction site, 5'-ATAGGATCCTCAACTGGACCACAGCCTCAGC-3'; TCR-beta4 sense with SalI restriction site, 5'-AGGTGTCGACTGACACTGCTATGGGCTCCATTTTCCTC-3'; and TCR-beta C2 terminus with BamHI restriction site, 5'-ATAGGATCCGGGTGAAGAACGGCTCAGGATGC-3' (all synthesized at Metabion). The rearranged TCR-alpha8.3 and TCR-beta4 chains from C3 cDNA were verified by sequencing. To eliminate a XhoI restriction site (CTC GAG) in TCR-beta4 at aa 116, GAG was changed into GAA, both coding for glutamate, using a site-directed mutagenesis kit (Agilent Technologies) with the following primer pair: Vbeta4 XhoI-Mut sense, 5'-CCAGACTGACTGTTCTCGAAGATCTGAGAAATGTG-3'; and Vbeta4 XhoI-Mut, 5'-CACATTTCTCAGATCTTCGAGAACAGTCAGCTGG-3'. The amino acid sequence of the CDR3 regions is as follows: TCalpha8.3, LYY CALSGGNNAPR FG (V8.3J4); and TCR-beta4, CASS QERT DSAE TLY (V4D1J2.3C2). The complete rearranged TCR chains were cloned into the pHSE3' vector (35), leading to expression under the control of the transgenic MHC class I H2-Kb promoter. XhoI-linearized TCR-containing plasmids were coinjected into the pronuclei of fertilized FVB oocytes. Transgenic founders were identified by PCR using a specific primer for C3 Valpha-Jalpha or Vbeta-Jbeta in combination with a pHSE3'-specific primer (TCR-alpha chain: mTCR-Valpha8.3-CDR3 sense, 5'-CTCCATAAGAGCAGCAGCTCC-3', and hu beta-globin antisense, 5'-CGTCTGTTTCCCATTCTAAACTGTACC-3'; TCR-beta chain: PH-2Kb sense, 5'-CTGGATATAAAGTCCACGCAGCC-3', and TCR-Vbeta4-CDR3 antisense, 5'-CAATCTCTGCTTTTGATGGCTCAAAC-3'). Transgenic mice were backcrossed for at least eight generations into the SJL/J background.
###end p 66
###begin title 67
EAE induction and scoring.
###end title 67
###begin p 68
###xml 157 183 149 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 157 183 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 821 826 <span type="species:ncbi:10090">mouse</span>
###xml 895 900 <span type="species:ncbi:10090">mouse</span>
Mice were injected s.c. at the back with 200 microl of recombinant MOG (200 microg), which was emulsified in Freund's adjuvant and supplemented with 3 mg/ml Mycobacterium tuberculosis (strain H37Ra). 200 ng of pertussis toxin was injected i.p. on days 0 and 2 after immunization. Clinical scoring of classical paralytic EAE was performed as follows: score 0, healthy; 1, flaccid tail; 1.5, flaccid tail and impaired righting reflex; 2, impaired righting reflex and hind limb weakness; 2.5, one hind leg paralyzed; 3, both hind legs paralyzed with residual mobility in both legs; 3.5, both hind legs completely paralyzed; 4, both hind legs completely paralyzed and beginning front limb paralysis; and 5, moribund or death of the animal after preceding clinical disease. Ataxic scoring was as follows: score 0, healthy; 1, mouse partly tilted, feet fall into cage fence; 2, tilted and tumbles; 3, mouse heavily tilted and moves in circles; 4, inability to walk, is only rolling. and 5, moribund. All animal procedures used were in accordance with guidelines of the committee on animals of the Max Planck Institute of Neurobiology and with the license of the Regierung von Oberbayern (Munich, Germany).
###end p 68
###begin title 69
Antigens.
###end title 69
###begin p 70
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 29 32 <span type="species:ncbi:10116">rat</span>
Recombinant histidine-tagged rat MOG protein (aa 1-125) was purified from bacterial inclusion bodies (36). MOG peptide 90-110 (SDEGGYTCFFRDHSYQEEAA), MOG 1-26 (GQFRVIGPGYPIRALVGDEAELPCRI), and MOG 92-106 (DEGGYTCFFRDHSYQ) were synthesized at the core facility of the Max Planck Institute of Biochemistry (Martinsried, Germany) or BioTrend (Koln, Germany). All antigens used in the study were of >95% purity, analyzed by silver staining of PAGE (proteins) or HPLC analysis (peptides).
###end p 70
###begin title 71
In vitro proliferation assay.
###end title 71
###begin p 72
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Proliferation assays were performed as previously described (2). Each sample was run in triplicates, the proliferative response of which is represented by the mean +/- SEM. All assays were replicated at least three times.
###end p 72
###begin title 73
ELISA.
###end title 73
###begin p 74
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Cytokine measurements and determination of serum titers of MOG-specific antibodies was performed as previously described (2). Antibodies were obtained from BD, except the anti-IL-17 which was obtained from R&D Systems. Each assay was repeated at least three times.
###end p 74
###begin title 75
Flow cytometric analysis.
###end title 75
###begin p 76
###xml 658 659 648 649 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Single cell suspensions were prepared from spleen, lymph node, thymus, or CNS tissue by mechanical disruption via forcing trough 40-microm cell strainers (BD). Erythrocytes of spleen cell suspensions were lysed by hypotonic treatment. CNS infiltrate cells were purified by Percoll gradient centrifugation. Cells were resuspended in Percoll (GE Healthcare) at a density of 1.035 g/ml and centrifuged over Percoll of a 1.08-g/ml density for 30 min at 20degreesC. The interphase was recovered and subjected to FACS analysis. For detection of cell surface markers by flow cytometric analysis, cells were stained in FACS medium (PBS containing 1% BSA and 0.1% NaN3) with different fluorochrome-labeled MAbs. For cytofluorometry, we used the FACSCalibur system with CellQuest software (BD), and for analysis we used WinMDI 2.9 software (Joe Trotter, The Scripps Institute, La Jolla, CA) was used. For intracellular cytokine staining, cells were first surface stained and then fixed and permeabilized in 4% PFA/0.1% saponin in Hepes-buffered HBSS, stained intracellularly, and washed. Before staining, cells were activated with 50 ng/ml PMA/500 ng/ml ionomycin in the presence of 5 microg/ml brefeldin A for 4 h. The following fluorochrome-labeled antibodies were purchased from BD or eBioscience: CD3 (145-2C11), CD4 (RM4-5), CD8 (53-6.7), Valpha8.3 (B21.14), Vbeta4 (KT4), CD11b (M1/70), CD45.1 (A20), CD19 (1D3), B220 (RA3-6B2), CD62L (MEL-14), CD25 (PC61), IFN-gamma (XMG1.2), IL-17 (TC11-18H10), and IgG1 (A85-1).
###end p 76
###begin title 77
Histological analysis.
###end title 77
###begin p 78
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 405 410 <span type="species:ncbi:10090">mouse</span>
###xml 419 422 <span type="species:ncbi:10116">rat</span>
###xml 423 428 <span type="species:ncbi:10090">mouse</span>
Brain and spinal cord tissue from mice fixed by perfusion with 4% phosphate buffered paraformaldehyde were embedded in paraffin. Paraffin sections were stained with H&E, with Luxol fast blue for myelin, and by Bielschowsky silver impregnation for visualization of neurons and axons. Adjacent serial sections were stained by immunocytochemistry, using primary antibodies directed against CD3, B220, Mac-3, mouse Ig, and rat/mouse complement C9 neoantigen. Immunocytochemistry was performed with a biotin avidin technique.
###end p 78
###begin title 79
Quantitative real-time TaqMan PCR analysis.
###end title 79
###begin p 80
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 1467 1469 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 115 120 <span type="species:ncbi:10090">mouse</span>
Real time quantitative PCR analysis was performed as previously described (2). Quantification of the expression of mouse immune and housekeeping genes was performed by Taqman PCR using the following primer/probe combinations: GAPDH sense, 5'-TCACCACCATGGAGAAGGC-3'; GAPDH antisense, 5'-GCTAAGCAGTTGGTGGTGCA-3'; GAPDH probe, 5'-ATGCCCCCATGTTTGTGATGGGTGT-3'; mIL-5 sense, 5'-CCGCTCACCGAGCTCTGTT-3'; mIL-5 antisense, 5'-AGATTTCTCCAATGCATAGCTGG-3'; IL-5 probe, 5'-CAGGAAGCCTCATCGTCTCATTGCTTGT-3'; mIL-10 sense, 5'-CAGAGAAGCATGGCCCAGAA-3'; mIL-10 antisense, 5'-TGCTCCACTGCCTTGCTCTT-3'; mIL-10 probe, 5'-TGAGGCGCTGTCATCGATTTCTCCC-3'; mIL-17 sense, 5'-AACTCCCTTGGCGCAAAAGT-3'; mIL-17 antisense, 5'-GGCACTGAGCTTCCCAGATC-3'; mIL-17 probe, 5'-CCACGTCACCCTGGACTCTCCACC-3'; mCD4 sense, 5'-CGTTTCCTCTCATCATCAATAAACTTA-3'; mCD4 antisense, 5'-GGCTGGTACCCGGACTGAAG-3'; mCD4 probe, 5'-CACTTTGAACACCCACAACTCCACCTCCT-3'; TCR-Valpha8.3 sense, 5'-CCACGCCACTCTCCATAAGAG-3'; TCR-Valpha8.3 antisense, 5'-CAGTAGTACAGGCCAGAGTCTGACA-3'; TCR-Valpha8.3 probe, 5'-CCTGAGCCAAAATACAGCGTTT-3'; TCR-Vbeta sense, 5'-TGATGACTCGGCCACATACTTC-3'; TCR-Vbeta4 antisense, 5'-AGCAGCTCCTTCCATCTGCAGAAGTCC-3'; TCR-Vbeta4 probe, 5'-TGCCAGCAGCCAAGAACGGACAGAT-3'; mFoxP3 sense, 5'-AGGAGAAGCTGGGAGCTATGC-3'; mFoxP3 antisense, 5'-TGGCTACGATGCAGCAAGAG-3'; and mFoxP3 probe, 5'-AAGGCTCCATCTGTGGCCTCAATGGA-3'. IFN-gamma, TNF-alpha, IL-4, IL-13, and IP-10 Taqman probes were synthesized as described in Giulietti et al. (37).
###end p 80
###begin title 81
Cell surface serum binding and complement assay.
###end title 81
###begin p 82
###xml 29 32 29 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mog</italic>
###xml 137 138 137 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 305 306 305 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 748 749 732 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 23 28 <span type="species:ncbi:10090">mouse</span>
###xml 226 231 <span type="species:ncbi:10090">mouse</span>
###xml 466 471 <span type="species:ncbi:10090">mouse</span>
###xml 569 575 <span type="species:ncbi:9986">rabbit</span>
For EL4-MOG cells, the mouse Mog cDNA was cloned into the retroviral vector pLXSN (Clontech Laboratories, Inc.) and transformed into a GP+E-86 packaging cell line. Virus-containing supernatant was used to stably transduce the mouse EL4 lymphoma cell line. EL4 and MOG-transduced EL4 cells (EL4-MOG; 2 x 105/well) were incubated with sera at the indicated dilutions for 30-45 min at 4degreesC, washed intensively, and thereafter either stained with biotinylated anti-mouse IgG1 (BD) and streptavidin-PE diluted at 1/150 and PI at 1 microg/ml or incubated with LOW-TOX-M rabbit complement (Cedarlane Laboratories) at a 1/10 dilution for 90 min at 37degreesC and thereafter analyzed for lysis by staining with PI. For analysis of binding only live (PI-) cells are gated for the histograms.
###end p 82
###begin title 83
Depletion of B cells.
###end title 83
###begin p 84
###xml 86 88 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 166 170 162 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
For B cell depletion, 20 microg of mouse anti-mouse CD20 (18B12; IgG2a; Biogen Idec) (38) or IgG2a control antibody (Sigma-Aldrich) was injected s.c. into 3-d-old TCR1640 mice. 2 wk later, pups were injected with 80 microg and, at 4 wk old, with 250 microg of respective antibodies. Injections were repeated thereafter at 2-wk intervals with 250 microg of respective antibodies.
###end p 84
###begin title 85
Serum transfer.
###end title 85
###begin p 86
###xml 57 61 57 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 307 311 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
###xml 137 140 <span type="species:ncbi:31658">CFA</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
Sera were obtained through retroorbital bleeding from TCR1640 or NTL. WT SJL/J mice were immunized with 100 microg PLP139-151 in 5 mg/ml CFA. 200 ng of Pertussis toxin was injected on days 0 and 2. When mice showed clinical EAE signs (score approximately1.0), they received i.p. injections of 250 microl TCR1640 serum or NTL serum or 8.18c5 mAb three times at 48-h intervals.
###end p 86
###begin title 87
Statistics.
###end title 87
###begin p 88
Differential spontaneous EAE incidence of female to males was analyzed by logrank test (by an in-built survival curve analysis function from Prism 4 [Graph Pad Software, Inc.]), and the effect of serum transfer on EAE development was analyzed by two-way ANOVA. P-values < 0.05 were considered to be significant.
###end p 88
###begin title 89
Online supplemental material.
###end title 89
###begin p 90
###xml 111 115 111 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 224 228 224 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 393 397 393 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 727 731 727 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1640</sup>
###xml 116 131 <span type="species:ncbi:10090">transgenic mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
###xml 398 402 <span type="species:ncbi:10090">mice</span>
###xml 450 455 <span type="species:ncbi:10090">mouse</span>
###xml 549 553 <span type="species:ncbi:10090">mice</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 732 736 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows the nature and encephalitogenicity of TCR donor clone C3. Fig. S2 shows the TCR expression in TCR1640 transgenic mice splenocytes. Fig. S3 illustrates the spontaneous disease course of individual transgenic TCR1640 animals. Fig. S4 shows the CNS messenger RNA expression analysis of spontaneous EAE- and MOG-immunized mice. Fig. S5 shows the efficiency of B cell depletion in TCR1640 mice. Video S1 shows one diseased double-transgenic mouse in different EAE stages. Table S1 shows a summary of spontaneous EAE in TCR transgenic SJL/J mice. Table S2 shows a summary of histological analysis of representative individual mice with spontaneous EAE. Table S3 summarizes spontaneous EAE incidence and mortality in TCR1640 mice treated with anti-CD20 and control isotype antibodies. Online supplemental material is available at .
###end p 90
###begin title 91
Supplementary Material
###end title 91
###begin title 92
[Supplemental Material Index]
###end title 92
###begin p 93
We are grateful to Irene Arnold-Ammer, Lydia Penner, Iris Jarsch, Michaela Krug, Marianne Leiszer, and Ulrike Kock for excellent technical support.
###end p 93
###begin p 94
This project was supported by the Deutsche Forschungsgemeinschaft (SFB 571, Project B6) and the Max Planck society. S.H. Domingues is supported by a PhD fellowship (Portuguese FCT program SFRH/BD/15885/2005).
###end p 94
###begin p 95
The authors have no conflicting financial interests.
###end p 95
###begin article-title 96
Experimental models of spontaneous autoimmune disease in the central nervous system.
###end article-title 96
###begin article-title 97
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation.
###end article-title 97
###begin article-title 98
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.
###end article-title 98
###begin article-title 99
Multiple sclerosis in the Japanese population.
###end article-title 99
###begin article-title 100
'The marvellous harmony of the nervous parts': The origins of multiple sclerosis.
###end article-title 100
###begin article-title 101
###xml 96 111 <span type="species:ncbi:10090">transgenic mice</span>
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice.
###end article-title 101
###begin article-title 102
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis.
###end article-title 102
###begin article-title 103
Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.
###end article-title 103
###begin article-title 104
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.
###end article-title 104
###begin article-title 105
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE.
###end article-title 105
###begin article-title 106
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Foxp3</italic>
Control of regulatory T cell development by the transcription factor Foxp3. 
###end article-title 106
###begin article-title 107
Molecular regulation of B lymphocyte response.
###end article-title 107
###begin article-title 108
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.
###end article-title 108
###begin article-title 109
Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination.
###end article-title 109
###begin article-title 110
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Selective unresponsiveness to conformational B cell epitopes of the myelin oligodendrocyte glycoprotein in H-2b mice.
###end article-title 110
###begin article-title 111
###xml 84 89 <span type="species:ncbi:9606">human</span>
Epitope specificity of demyelinating monoclonal autoantibodies directed against the human myelin oligodendrocyte glycoprotein.
###end article-title 111
###begin article-title 112
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor.
###end article-title 112
###begin article-title 113
Chronic relapsing necrotizing encephalomyelitis produced by myelin basic protein.
###end article-title 113
###begin article-title 114
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): Relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct.
###end article-title 114
###begin article-title 115
The immunology of inflammatory demyelinating disease. 
###end article-title 115
###begin article-title 116
McAlpine's Multiple Sclerosis. 
###end article-title 116
###begin article-title 117
T-cell properties determine disease site, clinical presentation, and cellular pathology of experimental autoimmune encephalomyelitis.
###end article-title 117
###begin article-title 118
Blood-brain barrier disruption and lesion localization in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement.
###end article-title 118
###begin article-title 119
Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.
###end article-title 119
###begin article-title 120
Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen.
###end article-title 120
###begin article-title 121
###xml 46 51 <span type="species:ncbi:10090">mouse</span>
Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis.
###end article-title 121
###begin article-title 122
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.
###end article-title 122
###begin article-title 123
Identification of a common idiotype of myelin oligodendrocyte glycoprotein-specific autoantibodies in chronic relapsing experimental allergic encephalomyelitis.
###end article-title 123
###begin article-title 124
B cells regulate autoimmunity by provision of IL-10.
###end article-title 124
###begin article-title 125
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis.
###end article-title 125
###begin article-title 126
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Spontaneous autoreactive memory B cell formation driven by a high frequency of autoreactive CD4+ T cells.
###end article-title 126
###begin article-title 127
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
###end article-title 127
###begin article-title 128
Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.
###end article-title 128
###begin article-title 129
Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis.
###end article-title 129
###begin article-title 130
Myelin oligodendrocyte glycoprotein is expressed in the peripheral nervous system of rodents and primates.
###end article-title 130
###begin article-title 131
###xml 23 24 23 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 76 91 <span type="species:ncbi:10090">transgenic mice</span>
T cell tolerance to Mlsa encoded antigens in T cell receptor Vbeta8.1 chain transgenic mice.
###end article-title 131
###begin article-title 132
###xml 154 157 <span type="species:ncbi:10116">rat</span>
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
###end article-title 132
###begin article-title 133
An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression.
###end article-title 133
###begin article-title 134
###xml 134 135 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Suppression of proteoglycan-induced arthritis by anti-CD20 B cell depletion therapy is mediated by reduction in autoantibodies and CD4+ T cell reactivity.
###end article-title 134
###begin p 135
###xml 305 308 <span type="species:ncbi:10116">rat</span>
Abbreviations used: cDNA, complementary DNA; CNS, central nervous system; EAE, experimental autoimmune encephalomyelitis; MOG, myelin oligodendrocyte glycoprotein; MS, multiple sclerosis; NTL, nontransgenic littermate; OSE, opticospinal EAE; OSMS, opticospinal MS; PI, propidium iodide; rMOG, recombinant rat MOG; RR, relapsing-remitting.
###end p 135

